Ramipril (Cadila Healthcare Limited)
Welcome to the PulseAid listing for the Ramipril drug offered from Cadila Healthcare Limited. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Cadila Healthcare Limited |
NON-PROPRIETARY NAME: | Ramipril |
SUBSTANCE NAME: | RAMIPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2010-11-20 |
END MARKETING DATE: | 0000-00-00 |
Ramipril HUMAN PRESCRIPTION DRUG Details:
Item Description | Ramipril from Cadila Healthcare Limited |
LABELER NAME: | Cadila Healthcare Limited |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 1.25(mg/1) |
START MARKETING DATE: | 2010-11-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 65841-655_c62e7e6a-2df7-4283-b3b5-a9449a426eeb |
PRODUCT NDC: | 65841-655 |
APPLICATION NUMBER: | ANDA078832 |
Other RAMIPRIL Pharmaceutical Manufacturers / Labelers: